Advertisement

Index by author

October 01, 1996; Volume 24,Issue 10

A

  1. Anderson, B D

    1. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
      D Singhal, M E Morgan and B D Anderson
      Drug Metabolism and Disposition October 1996, 24 (10) 1155-1161;

  2. Assmann, G

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

B

  1. Balani, S K

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

  2. Beattie, I

    1. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

  3. Benninghoven, A

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

  4. Bible, R

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  5. Birkmeier, J

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  6. Brophy, P

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

  7. Brune, K

    1. Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

C

  1. Chen, I W

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

  2. Chiba, M

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

  3. Christians, U

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

  4. Coleman, N L

    1. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;

  5. Collington, J

    1. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

  6. Cooper, A E

    1. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

D

  1. Danielson, T J

    1. Systemic clearance and demethylation of caffeine in sheep and cattle.
      T J Danielson and L R Golsteyn
      Drug Metabolism and Disposition October 1996, 24 (10) 1058-1061;

  2. Drobitch, R K

    1. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;

E

  1. Erb, K

    1. Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

  2. Erren, M

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

F

  1. Farid, N A

    1. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;

  2. Fobker, M

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

  3. Fournel-Gigleux, S

    1. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;

  4. Fromm, M F

    1. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

G

  1. Geisslinger, G

    1. Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

  2. Ghanayem, B I

    1. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;

  3. Goldstein, J A

    1. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;

  4. Golsteyn, L R

    1. Systemic clearance and demethylation of caffeine in sheep and cattle.
      T J Danielson and L R Golsteyn
      Drug Metabolism and Disposition October 1996, 24 (10) 1058-1061;

  5. Gray, A J

    1. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

H

  1. Hajdu, E

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  2. Heidemann, H

    1. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

  3. Hensel, R

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

  4. Holtbecker, N

    1. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

  5. Hrib, N

    1. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
      A E Mutlib, J Jurcak and N Hrib
      Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;

  6. Hribar, J D

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

I

  1. Ionac, M

    1. Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

J

  1. Jurcak, J

    1. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
      A E Mutlib, J Jurcak and N Hrib
      Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;

K

  1. Karam, W G

    1. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;

  2. Kocarek, T A

    1. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
      M Runge-Morris, K Rose and T A Kocarek
      Drug Metabolism and Disposition October 1996, 24 (10) 1095-1101;

  3. Kroemer, H K

    1. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

  4. Kwei, G Y

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

L

  1. Lapicque, F

    1. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;

  2. Lasker, J M

    1. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;

  3. Lin, J H

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

  4. Liu, N

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  5. Logan, C J

    1. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

  6. Loullis, C

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

M

  1. Magdalou, J

    1. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;

  2. McLellan, R A

    1. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;

  3. Mehvar, R

    1. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding.
      R Mehvar and J Reynolds
      Drug Metabolism and Disposition October 1996, 24 (10) 1088-1094;

  4. Meyer, K

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

  5. Monshouwer, M

    1. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;

  6. Morgan, M E

    1. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
      D Singhal, M E Morgan and B D Anderson
      Drug Metabolism and Disposition October 1996, 24 (10) 1155-1161;

  7. Mullin, M E

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

  8. Murray, E

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

  9. Mutlib, A E

    1. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
      A E Mutlib, J Jurcak and N Hrib
      Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;

N

  1. Netter, P

    1. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;

  2. Nishime, J A

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

O

  1. Obach, R S

    1. The importance of nonspecific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism reactions, and implications for in vitro-in vivo correlations.
      R S Obach
      Drug Metabolism and Disposition October 1996, 24 (10) 1047-1049;

  2. Oelkers, R

    1. Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

  3. Ohnhaus, E E

    1. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

P

  1. Pollack, G M

    1. Comparative toxicokinetics of methanol in pregnant and nonpregnant rodents.
      K W Ward and G M Pollack
      Drug Metabolism and Disposition October 1996, 24 (10) 1062-1070;

  2. Presle, N

    1. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;

R

  1. Renton, K W

    1. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;

  2. Reynolds, J

    1. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding.
      R Mehvar and J Reynolds
      Drug Metabolism and Disposition October 1996, 24 (10) 1088-1094;

  3. Ricca, G

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

  4. Rock, M

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  5. Rose, K

    1. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
      M Runge-Morris, K Rose and T A Kocarek
      Drug Metabolism and Disposition October 1996, 24 (10) 1095-1101;

  6. Runge-Morris, M

    1. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
      M Runge-Morris, K Rose and T A Kocarek
      Drug Metabolism and Disposition October 1996, 24 (10) 1095-1101;

S

  1. Schoenhard, G

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  2. Schreiner, K M

    1. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;

  3. Seddon, H

    1. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

  4. Sewing, K F

    1. Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

  5. Singhal, D

    1. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
      D Singhal, M E Morgan and B D Anderson
      Drug Metabolism and Disposition October 1996, 24 (10) 1155-1161;

V

  1. Van Lier, R B

    1. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;

  2. Vastag, K J

    1. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

W

  1. Ward, K W

    1. Comparative toxicokinetics of methanol in pregnant and nonpregnant rodents.
      K W Ward and G M Pollack
      Drug Metabolism and Disposition October 1996, 24 (10) 1062-1070;

  2. Wells, D S

    1. Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

  3. Wrighton, S A

    1. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;

Y

  1. Yang, D C

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

  2. Yuan, J H

    1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
Back to top

In this issue